We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
MYR Group
MYRG
$5.14B
| $4.57M | 0.01% |
51,813
-10,146
| -16% | -$888K |
|
827
Radian Group
RDN
$4.86B
| $4.51M | 0.01% |
229,400
+79,969
| +54% | +$1.68M |
|
828
Matador Resources
MTDR
$6.51B
| $4.45M | 0.01% |
95,557
+2,460
| +3% | +$134K |
|
829
Diamondback Energy
FANG
$56.5B
| $4.41M | 0.01% |
36,413
-12,419
| -25% | -$1.7M |
|
830
Burlington
BURL
$22.6B
| $4.4M | 0.01% |
32,316
+15,055
| +87% | +$2.72M |
|
|
HBI
831
DELISTED
Hanesbrands
HBI
| $4.39M | 0.01% |
432,298
+102,227
| +31% | +$1.27M |
|
832
Boeing
BA
$184B
| $4.37M | 0.01% |
31,963
-37,297
| -54% | -$5.5M |
|
833
Illumina
ILMN
$29.1B
| $4.37M | 0.01% |
24,714
-19,459
| -44% | -$4.97M |
|
834
Ball Corp
BALL
$16.6B
| $4.36M | 0.01% |
64,532
+7,809
| +14% | +$593K |
|
835
Graco
GGG
$13.5B
| $4.36M | 0.01% |
74,064
-48,787
| -40% | -$3.07M |
|
836
CBRE Group
CBRE
$42.7B
| $4.35M | 0.01% |
60,231
+27
| +0% | +$2.17K |
|
837
UFP Industries
UFPI
$5.12B
| $4.34M | 0.01% |
63,664
+2,212
| +4% | +$167K |
|
838
Roper Technologies
ROP
$39.5B
| $4.3M | 0.01% |
11,029
-14,013
| -56% | -$6.09M |
|
839
BellRing Brands
BRBR
$1.34B
| $4.3M | 0.01% |
175,824
+164,146
| +1,406% | +$4.02M |
|
840
CenterPoint Energy
CNP
$26.5B
| $4.29M | 0.01% |
+147,528
| New | +$4.54M |
|
841
Matsons
MATX
$6.11B
| $4.29M | 0.01% |
58,791
+3,399
| +6% | +$292K |
|
842
Sanmina
SANM
$10.9B
| $4.28M | 0.01% |
105,098
+5,297
| +5% | +$219K |
|
843
CEMIG Preferred Shares
CIG
$5.64B
| $4.28M | 0.01% |
2,752,751
-248,523
| -8% | -$436K |
|
844
Essex Property Trust
ESS
$18.2B
| $4.27M | 0.01% |
16,451
+7,549
| +85% | +$2.28M |
|
|
JKS
845
JinkoSolar
JKS
$873M
| $4.26M | 0.01% |
61,532
| – | – |
|
846
Televisa
TV
$1.48B
| $4.25M | 0.01% |
519,834
+200,496
| +63% | +$1.89M |
|
847
Adient
ADNT
$1.48B
| $4.25M | 0.01% |
144,995
+113,743
| +364% | +$3.82M |
|
848
Deckers Outdoor
DECK
$12.8B
| $4.25M | 0.01% |
101,904
-228,144
| -69% | -$9.96M |
|
849
Tronox
TROX
$1.02B
| $4.19M | 0.01% |
249,153
+28,016
| +13% | +$507K |
|
850
PNC Financial Services
PNC
$101B
| $4.17M | 0.01% |
27,251
-2,270
| -8% | -$380K |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.